Understanding how glutamate is transported into nerve cells
Glutamate Transport into Synaptic Vesicles
This study looks at how a brain chemical called glutamate gets packed into tiny storage bubbles in nerve cells, which is really important for how brain cells talk to each other, and the findings could help improve treatments for conditions that affect brain signaling.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10991045 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which glutamate, a key neurotransmitter, is transported into synaptic vesicles in nerve cells. It focuses on how changes in ion gradients and other factors influence this transport process, which is crucial for effective communication between neurons. By studying the properties of vesicular glutamate transporters (VGLUTs) and their regulation, the research aims to uncover how these processes affect neurotransmission. Patients may benefit from insights gained about excitatory signaling in the brain, which could inform treatments for neurological conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with neurological conditions that involve glutamate dysregulation.
Not a fit: Patients with conditions unrelated to glutamate signaling or synaptic transmission may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for neurological disorders related to glutamate signaling.
How similar studies have performed: Previous research has shown success in understanding neurotransmitter transport mechanisms, indicating that this approach has a solid foundation.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Edwards, Robert H — University of California, San Francisco
- Study coordinator: Edwards, Robert H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.